Baxter International Inc. (BAX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Baxter International ( BAX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.1%. By the end of trading, Baxter International fell $1.69 (-2.6%) to $63.89 on heavy volume. Throughout the day, 8,308,521 shares of Baxter International exchanged hands as compared to its average daily volume of 2,592,500 shares. The stock ranged in price between $62.80-$64.94 after having opened the day at $64.89 as compared to the previous trading day's close of $65.58. Other companies within the Health Services industry that declined today were: Span-America Medical ( SPAN), down 12.8%, Vision-Sciences Inc (DE ( VSCI), down 10.1%, Synergetics USA ( SURG), down 8.6% and MiMedx Group ( MDXG), down 7.3%.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $38.7 billion and is part of the health care sector. Shares are up 6.9% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

On the positive front, Fonar Corporation ( FONR), up 20.8%, Hansen Medical ( HNSN), up 15.1%, Edap TMS ( EDAP), up 11.6% and Mazor Robotics ( MZOR), up 7.0% , were all gainers within the health services industry with HCA Holdings ( HCA) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Trade War With China Won't Cure U.S. Trade Deficit, N.Y. Fed Note Says

Trade War With China Won't Cure U.S. Trade Deficit, N.Y. Fed Note Says

Bitcoin Falls but Trades Above $6,000

Bitcoin Falls but Trades Above $6,000

Turkey's Issues Are Likely to Keep a Ceiling on the S&P 500 of 2,850

Turkey's Issues Are Likely to Keep a Ceiling on the S&P 500 of 2,850

Tesla CEO Elon Musk Is Embarrassing the Short-Sellers

Tesla CEO Elon Musk Is Embarrassing the Short-Sellers

Is the S&P 500 Headed for a Bruising Double Top Reversal?

Is the S&P 500 Headed for a Bruising Double Top Reversal?